Peter Gunning
Corporate Officer/Principal chez UNSW School of Medical Sciences
Provenance du réseau au premier degré de Peter Gunning
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Gunning via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member | |
| PERCHERON THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman | |
| TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chairman | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Founder | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Executive Officer | |
Quadrant Healthcare Plc
 Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | President | |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | Chairman | |
| University of California, Berkeley | College/University | Masters Business Admin | |
| The University of Queensland | College/University | Graduate Degree | |
| The University of Sydney | College/University | Undergraduate Degree | |
Powerstax Ltd.
 Powerstax Ltd. Electrical ProductsProducer Manufacturing Powerstax Ltd. designs, manufactures and sells power conversion systems. It specializes in the design and manufacture of AC-DC and DC-DC power supplies including DC-DC converters, transformer rectifiers, configurable, modular and bulk power switched mode power supplies. The firm provides value-added and custom power supply solutions for markets including defence, medical, electro-chlorination, cathodic protection, aerospace, fuel cells, oil and gas and others. The company was founded in 1992 and is headquartered in Farnborough, the United Kingdom. | Electrical Products | Director/Board Member | |
| University College London | College/University | Undergraduate Degree | |
| Royal Holloway University of London | College/University | Corporate Officer/Principal | |
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Medical Specialties | Director/Board Member | |
| Massey University | College/University | Undergraduate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Australian Association
 American Australian Association Miscellaneous Commercial ServicesCommercial Services American Australian Association is a non-profit organization whose purpose is to promote friendship, cooperation and understanding between the peoples of the United States and Australia through a better understanding of their cultures and societies. The company was founded by Keith Murdoch in 1948 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Biomer Technology Ltd.
 Biomer Technology Ltd. Pharmaceuticals: MajorHealth Technology Biomer Technology Ltd. designs and develops biomaterial products for medical device industry. It develops medical device and therapeutic applications, and engineered polymers; designing and manufacturing industrial grade polymers, including high temperature polyurethanes HTTPU’s, for component and device manufacture. The company was founded in 2003 by Iain Gladstone Ross and is headquartered in Runcorn, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan. | Pharmaceuticals: Major | President | |
Allergan Biologics Ltd.
 Allergan Biologics Ltd. BiotechnologyHealth Technology Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million. | Biotechnology | Director/Board Member | |
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| Aldershot Town Football Club | Director/Board Member | ||
| PALA PHAR | Pharmaceuticals: Major | Director/Board Member | |
Triaxial Pharmaceuticals Pty Ltd.
 Triaxial Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Kazia Therapeutics Ltd., Triaxial Pharmaceuticals Pty Ltd. is an Australian company that develops bio-pharmaceutical technologies. The company is based in Sydney, Australia. Triaxial Pharmaceuticals was acquired by Kazia Therapeutics Ltd. on December 06, 2012 for $3.08 million. | Pharmaceuticals: Major | Chairman | |
Redx Oncology Ltd.
 Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Pharmaceuticals: Major | Director/Board Member | |
| Takeda Pharmaceuticals Australia Pty Ltd. | Chief Tech/Sci/R&D Officer | ||
| Novogen North America, Inc. | Chief Executive Officer | ||
| Kumara, Inc. | President | ||
| Nutraceutical & Natural Products AG | Chairman | ||
| American New Zealand Association, Inc. | Chairman | ||
| NOXOPHARM LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| NYRADA INC. | Pharmaceuticals: Major | Founder | |
| BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman | |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
| Royaume-Uni | 21 |
| Australie | 13 |
| Etats-Unis | 11 |
| Suisse | 3 |
| Suède | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Health Services | 2 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 38 |
| Chairman | 25 |
| Chief Executive Officer | 12 |
| Independent Dir/Board Member | 9 |
| Corporate Officer/Principal | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| Iain Ross | 41 |
| Bryce D. Carmine | 8 |
| James Garner | 7 |
| Graham Edmund Kelly | 6 |
| Ian M. Phillips | 5 |
| Peng Leong | 3 |
| Andrew Heaton | 2 |
| Robert Birch | 1 |
- Bourse
- Insiders
- Peter Gunning
- Connexions Sociétés
